Search research articles
Contact Us
Filters
Showing results (951-960 of 998) with videos related to
Page
of 100
Sort By:
Eukaryotic Cell
|
April 10, 2003
Novel small-molecule inhibitors of RNA polymerase III
Liping Wu, Jing Pan, Vala Thoroddsen, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
July 31, 2024
Precise Identification of Glioblastoma Micro-Infiltration at Cellular Resolution by Raman Spectroscopy
Lijun Zhu, Jianrui Li, Jing Pan, et al.
Journal of Advanced Research
|
December 10, 2023
Rapid visualization of PD-L1 expression level in glioblastoma immune microenvironment via machine learning cascade-based Raman histopathology
Qing-Qing Zhou, Jingxing Guo, Ziyang Wang, et al.
Journal of the International Society of Sports Nutrition
|
September 22, 2023
Effect of vitamin D<sub>3</sub> supplementation in winter on physical performance of university students: a one-month randomized controlled trial
Xiao-Li Zhang, Qing Zhang, Xu Zhang, et al.
Chinese Medical Journal
|
June 21, 2023
Contactless evaluation of rigidity in Parkinson's disease by machine vision and machine learning
Xue Zhu, Weikun Shi, Yun Ling, et al.
Journal of the National Cancer Institute
|
January 25, 2012
Pooled analysis of a self-sampling HPV DNA Test as a cervical cancer primary screening method
Fang-Hui Zhao, Adam K Lewkowitz, Feng Chen, et al.
Nature Medicine
|
October 1, 2024
Allogeneic CD5-specific CAR-T therapy for relapsed/refractory T-ALL: a phase 1 trial
Jing Pan, Yue Tan, Lingling Shan, et al.
Nature Medicine
|
October 16, 2024
Publisher Correction: Allogeneic CD5-specific CAR-T therapy for relapsed/refractory T-ALL: a phase 1 trial
Jing Pan, Yue Tan, Lingling Shan, et al.
Chinese Medical Journal
|
March 19, 2024
Motor symptom machine rating system for complete MDS-UPDRS III in Parkinson's disease: A proof-of-concept pilot study
Xue Zhu, Zhonglue Chen, Yun Ling, et al.
The Lancet. Oncology
|
October 20, 2023
Sequential CD19 and CD22 chimeric antigen receptor T-cell therapy for childhood refractory or relapsed B-cell acute lymphocytic leukaemia: a single-arm, phase 2 study
Jing Pan, Kaiting Tang, Yuechen Luo, et al.
Page
of 100
Search research articles
Search
Showing results (951-960 of 998) with videos related to
Sort By:
Page
of 100
Eukaryotic Cell
|
April 10, 2003
Novel small-molecule inhibitors of RNA polymerase III
Liping Wu, Jing Pan, Vala Thoroddsen, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
July 31, 2024
Precise Identification of Glioblastoma Micro-Infiltration at Cellular Resolution by Raman Spectroscopy
Lijun Zhu, Jianrui Li, Jing Pan, et al.
Journal of Advanced Research
|
December 10, 2023
Rapid visualization of PD-L1 expression level in glioblastoma immune microenvironment via machine learning cascade-based Raman histopathology
Qing-Qing Zhou, Jingxing Guo, Ziyang Wang, et al.
Journal of the International Society of Sports Nutrition
|
September 22, 2023
Effect of vitamin D<sub>3</sub> supplementation in winter on physical performance of university students: a one-month randomized controlled trial
Xiao-Li Zhang, Qing Zhang, Xu Zhang, et al.
Chinese Medical Journal
|
June 21, 2023
Contactless evaluation of rigidity in Parkinson's disease by machine vision and machine learning
Xue Zhu, Weikun Shi, Yun Ling, et al.
Journal of the National Cancer Institute
|
January 25, 2012
Pooled analysis of a self-sampling HPV DNA Test as a cervical cancer primary screening method
Fang-Hui Zhao, Adam K Lewkowitz, Feng Chen, et al.
Nature Medicine
|
October 1, 2024
Allogeneic CD5-specific CAR-T therapy for relapsed/refractory T-ALL: a phase 1 trial
Jing Pan, Yue Tan, Lingling Shan, et al.
Nature Medicine
|
October 16, 2024
Publisher Correction: Allogeneic CD5-specific CAR-T therapy for relapsed/refractory T-ALL: a phase 1 trial
Jing Pan, Yue Tan, Lingling Shan, et al.
Chinese Medical Journal
|
March 19, 2024
Motor symptom machine rating system for complete MDS-UPDRS III in Parkinson's disease: A proof-of-concept pilot study
Xue Zhu, Zhonglue Chen, Yun Ling, et al.
The Lancet. Oncology
|
October 20, 2023
Sequential CD19 and CD22 chimeric antigen receptor T-cell therapy for childhood refractory or relapsed B-cell acute lymphocytic leukaemia: a single-arm, phase 2 study
Jing Pan, Kaiting Tang, Yuechen Luo, et al.
Page
of 100